Skip to main content

Advertisement

Log in

Spermidine level as a parameter in the treatment of patients with malignant melanoma

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Before, during, and after 19 courses of chemotherapy given to patients with disseminated malignant melanoma plasma spermidine levels were determined with a radioimmunoassay. Baseline values were normal in 17 courses, a doubling of plasma levels following chemotherapy occurred in 13 courses. There was no relation between the occurrence of a tumor response and an increase in spermidine levels nor between hematological toxicity or digestive tract toxicity and spermidine levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Durie BGM, Salmon SE, Russell DH (1977) Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 27:214–221

    Google Scholar 

  2. Hrusherky WJM, Merdink J, Abdel-Monem MM (1983) Circadian rhythmicity of polyamine excretion. Cancer Res 43:3944–3947

    Google Scholar 

  3. Roth H, Kitta D, Jones GRN, Osswald H, Kunz W (1981) Polyamine responses in a solid transplanted tumor (S180) in liver and urine during endotoxin-induced tumor injury in the mouse. Cancer 48:945–950

    Google Scholar 

  4. Russell DH, Levy CC (1971) Polyamines accumulation and biosynthesis in a mouse L1210 leukemia. Cancer Res 31:248–251

    Google Scholar 

  5. Russell DH, Levy CC, Schimpf SC, Hawk IA (1971) Urinary polyamines in cancer patients. Cancer Res 31:1555–1558

    Google Scholar 

  6. Russell DH, Looney WB, Kovacs CJ, Hopkins HA, Marton LJ, LeGendre SM, Morris HP (1974) Polyamine depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924 A hepatomas after 5-fluorouracil administration. Cancer Res 34:2382–2385

    Google Scholar 

  7. Townsend RM, Banda PW, Marton LJ (1976) Polyamines in malignant melanoma. Cancer 38:2088–2092

    Google Scholar 

  8. Van Dobbenburgh OA, Houwen B, Jurjens H, Marrink J, Halie MR, Nieweg HO (1983) Plasma spermidine, concentrations as early indication of response to therapy in human myeloma. J Clin Pathol 36:804–807

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smit, J.M., Jurjens, H., Bouman, J. et al. Spermidine level as a parameter in the treatment of patients with malignant melanoma. Eur J Nucl Med 10, 276–277 (1985). https://doi.org/10.1007/BF00254474

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254474

Key words

Navigation